FDA approves Vivitrol for treatment of opioid-dependent patients

Published October 18, 2010

FDA approves Vivitrol for treatment of opioid-dependent patients
The U.S. Food and Drug Administration today approved Vivitrol to treat and prevent relapse after patients with opioid dependence have undergone detoxification treatment.
Read more on News-Medical-Net

Alkermes Aims Higher with New Indication for Vivitrol
With its FDA approval this week, Vivitrol becomes the first non-addictive, non-narcotic, once-monthly treatment for opioid dependence, serving a potential market of 1.3 million addicts in the U.S.
Read more on BioWorld